| Literature DB >> 20981145 |
Rihito Morita1, Shuhei Nakane, Atsuhiro Shimada, Masao Inoue, Hitoshi Iino, Taisuke Wakamatsu, Kenji Fukui, Noriko Nakagawa, Ryoji Masui, Seiki Kuramitsu.
Abstract
DNA is subjected to many endogenous and exogenous damages. All organisms have developed a complex network of DNA repair mechanisms. A variety of different DNA repair pathways have been reported: direct reversal, base excision repair, nucleotide excision repair, mismatch repair, and recombination repair pathways. Recent studies of the fundamental mechanisms for DNA repair processes have revealed a complexity beyond that initially expected, with inter- and intrapathway complementation as well as functional interactions between proteins involved in repair pathways. In this paper we give a broad overview of the whole DNA repair system and focus on the molecular basis of the repair machineries, particularly in Thermus thermophilus HB8.Entities:
Year: 2010 PMID: 20981145 PMCID: PMC2957137 DOI: 10.4061/2010/179594
Source DB: PubMed Journal: J Nucleic Acids ISSN: 2090-0201
Figure 1Different repair systems for the principal types of DNA lesion produced by a wide range of factors. UV-light induces cyclobutane pyrimidine dimers or (6-4) photoproducts that are repaired by nucleotide excision repair and direct reversal systems. Alkylating agents can modify all of the bases and the phosphates of the DNA, and some repair proteins remove these alkyl adducts in a direct manner. Oxygen radicals modify DNA, and the base excision repair system acts to reverse these changes. The main cause of spontaneous mutation is deamination, and base excision repair and alternative repair systems remove the lesions. Other bulky adducts or interstrand cross-links are repaired by the nucleotide excision repair system. The mismatch repair pathway repairs replication errors. Double-strand breaks and four-way junctions are induced by X-rays and are repaired by recombinational repair.
Distribution of DNA repair genes. ∗1Related human diseases are listed by referencing the following databases: KEGG disease (http://www.genome.jp/kegg/disease/), GeneCards (http://www.genecards.org/), and Online Mendelian Inheritance in Man (http://www.ncbi.nlm.nih.gov/omim). ∗2Descriptions in the parentheses indicate the subunit organizations of holoenzymes.
| Repair pathways | Molecular functions | Related disease∗1 | ||||||
|---|---|---|---|---|---|---|---|---|
| Photoreactivation | Photoreactivation | Phr (TTHB102) | PhrA | PHR1 | PhrB | |||
| Alkyltransfer | Alkyltransfer or recognition | ATL (TTHA1564) | Ada, AGT, ATL | MGT1 | MGMT | MGMT | ||
| alkyltransfer | AlkB | AlkBH1 | ALKBH2, ALKBH3 | |||||
| Base excision | Remove ring-saturated or fragmented pyrimidines | EndoIII (TTHA0112) | Nth (EndoIII) | Ntg1p, Ntg2p | AT1G05900 | Nthl1 | NTHL1 | |
| remove 3-meA, ethenoA, hypoxanthine | AlkA (TTHA0329) | AlkA, TagA | Mag1p | AT3G12040 (MAG) | Mpg | MPG, (MAG, AAG) | ||
| Remove U | UDGA (TTHA0718) | Ung | Ung1p | AT3G18630 uracil DNA glycosylase family protein | Ung | Ung | Hyper IgM syndromes, autosomal recessive type | |
| UDGB (TTHA1149) | ||||||||
| Remove U, hydroxymethyl U | Smug1 | SMUG1 | ||||||
| Remove U or T opposite G at CpG sequences | Mbd4 | MBD4 (MED1) | ||||||
| Remove U, T, or ethenoC opposite G | Mug | Tdg | TDG | |||||
| Remove 8-oxoG opposite C | MutM (TTHA1806) | Fpg (MutM) | Ogg1p | OGG1 | Ogg1 | OGG1 | Lung cancer | |
| Remove A opposite 8-oxoG | MutY (TTHA1898) | MutY | AT4G12740 (MYH-related) | MUTYH | MUTYH | |||
| Remove thymine glycol | Nei (EndoVIII) | Neil1 | NEIL1 | |||||
| Remove oxidative products of C, U | NEIL2 | |||||||
| Not known | NEIL3 | |||||||
| Alternative strand incision | Incision 3′ of hypoxanthine and uracil | EndoV (TTHA1347) | Nfi (EndoV) | EndoV | EndoV | EndoV | ||
| AP site processing and resynthesis | AP endonuclease | EndoIV (Nfo) (TTHA0834) | Nfo (EndoIV) | Apn1p | ||||
| AP endonuclease | XthA (ExoIII) | Apn2p (Eyh1) | ARP | Apex1 | APEX1 (APE1, APEX, HAP1, REF1), | |||
| AP endonuclease | AT4G36050 | Apex2 | APEX2 | |||||
| gap-filling DNA polymerase | PolX (TTHA1150) | Pol | Pol | |||||
| DNA polymerase, 5′ flap endonuclease | PolI (TTHA1054) | PolI | ||||||
| replication and BER in mitochondrial DNA | Mip1p | Pol | Pol | |||||
| NAD-dependent DNA ligase | LigA (TTHA1097) | LigA | ||||||
| ATP-dependent DNA ligase | AT1G66730 (ATP-dependent) | Lig3 (ATP-dependent) | LIG3 (ATP-dependent) | |||||
| accessory factor for LIG3 and BER | AT1G80420 (putative XRCC1) | Xrcc1 | XRCC1 | |||||
| poly (ADP-ribose) polymerase | PARP2 | Parp1 | PARP1 (ADPRT) | |||||
| ADPRT-like enzyme | APP (Arabidopsis poly(ADP-ribose) polymerase) | Parp2 | PARP2 (ADPRTL2) | |||||
| DNA binding | Bind damaged DNA in complex with UvrB | UvrA (TTHA1440) | UvrA | |||||
| Catalyze unwinding in preincision complex | UvrB (TTHA1892) | UvrB | ||||||
| Bind disordered DNA as complex | RAD4 | RAD4 | Xpc | XPC | Xeroderma pigmentosum (XP) | |||
| Bind disordered DNA as complex | RAD23 | RAD23 | Rad23b (Hr23b) | RAD23B (HR23B) | ||||
| RAD23B paralog | Rad23a (Hr23a) | RAD23A (HHR23A) | ||||||
| Bind DNA and proteins in preincision complex | RAD14 | Xpa | XPA | XP, | ||||
| TFIIH subunits | 3′-5′ DNA helicase TFIIH subunit | SSL2 (RAD25) | XPB2 | Xpb (Ercc3) | XPB (ERCC3) | XP, Cockayne syndrome (CS), Trichothiodystrophy (TTD) | ||
| 5′-3′ DNA helicase TFIIH subunit | RAD3 | UVH6 | Xpd (Ercc2) | ERCC2 | XP, CS, TTD | |||
| TFIIH subunit p62 | TFB1 | AT1G55750 | Gtf2h1 | GTF2H1 | ||||
| TFIIH subunit p44 | SSL1 | GTF2H2 | Gtf2h2 | GTF2H2 | ||||
| TFIIH subunit p34 | TFB4 | AT1G18340 | Gtf2h3 | GTF2H3 | ||||
| TFIIH subunit p52 | TFB2 | AT4G17020 | Gtf2h4 | GTF2H4 | ||||
| TFIIH subunit p8 | TFB5 | AT1G12400 | Gtf2h5 | GTF2H5 (TTDA) | TTD | |||
| Kinase subunits of TFIIH | KIN28 | CDKD1;3 | Cdk7 | CDK7 | ||||
| Kinase subunits of TFIIH | CCL1 | CYCH;1 | Ccnh | CCNH | ||||
| THIIH subunit | TFB3 | AT4G30820 | Mnat1 (Mat1) | MNAT1 (MAT1) | ||||
| Strand incision and excision | 3′ and 5′ incision nuclease | UvrC (TTHA1548) | UvrC | |||||
| 3′ incision nuclease | Cho | |||||||
| 3′ incision nuclease | RAD2 | UVH3 | Xpg (Ercc5) | ERCC5 | XP, CS | |||
| 5′ incision nuclease subunits | RAD10 | ERCC1 | Ercc1 | ERCC1 | XP | |||
| 5′ incision nuclease subunits | RAD1 | UVH1 | Xpf (Ercc4) | ERCC4 | XP | |||
| Separating two annealed strands | DNA helicase | UvrD (TTHA1427) | UvrD | |||||
| Other factors | Transcription- repair coupling factor | Mfd (TTHA0889) | Mfd | |||||
| Cockayne syndrome, needed for TC-NER | ERCC6 | Csb (Ercc6) | CSB (ERCC6) | CS, UV-sensitive syndrome (UVS) | ||||
| Cockayne syndrome, needed for TC-NER | AT1G19750 | Csa (Ckn1, Ercc8) | CSA (ERCC8) | CS | ||||
| P127 subunit of DDB | DDB1 | Ddb1 | DDB1 (XPE) | |||||
| P48 subunit of DDB, defective in XP-E | DDB2 | Ddb2 (Xpe) | DDB2 (XPE) | XP | ||||
| transcription and NER | AT5G48120 | Mms19 | MMS19 | |||||
| Mismatch recognition | DNA-binding ATPase | MutS (TTHA1324) | MutS | MutS | MutS | MutS | MutS | Colorectal cancer, Ovarian cancer |
| Strand incision | Activation of MutL homologue | DNA polymerase III, | — | PCNA | PCNA | PCNA | PCNA | |
| Activation of MutL homologue | DNA polymerase III, | RFC (RFC1-5)∗2 | RFC (RFC1-5)∗2 | RFC (RFC1-5)∗2 | RFC (RFC1-5)∗2 | |||
| Endonuclease ATPase | MutL (TTHA1323) | — | MutL | MutL | MutL | MutL | Colorectal cancer, Endometrial cancer, Ovarian cancer | |
| Match making | ATPase | — | MutL | — | — | — | — | |
| Strand excision | 5′-3′ exonuclease | RecJ (TTHA1167) | RecJ | |||||
| 3′-5′ exonuclease | ExoI (TTHB178) | ExoI | ||||||
| 5′-3′ exonuclease | ExoVII | |||||||
| 3′-5′ exonuclease | ExoX | |||||||
| 5′-3′ exonuclease | EXO1 | AT1G29630 | Exo1 | EXO1 | ||||
| Single-stranded DNA binding protein | SSB (TTHA0244) | SSB | ||||||
| Single-stranded DNA binding protein complex | RFA (RFA1-3)∗2 | RPA (RPA1-3)∗2 | Rpa (Rpa1-3)∗2 | RPA (RPA1-3)∗2 | ||||
| DNA helicase | UvrD (TTHA1427) | UvrD | ||||||
| End resection and recombinase loading | 5′-3′ exonuclease | RecJ (TTHA1167) | RecJ | |||||
| 5′-3′ exonuclease | EXO1 | AT1G29630 | Exo1 | EXO1 | ||||
| 5′-flap endonuclease | DNA2 | AT1G08840 | Dna2 | DNA2 | ||||
| RECQ family DNA helicase | RecQ | SGS1 | AT1G10930 (RECQ4A) | Blm | BLM | Bloom syndrome | ||
| Endonuclease, interact with MRN complex | SAE2 | AT3G52115 (ATGR1) | CtIP (Rbbp8) | CTIP (RBBP8) | ||||
| SMC-like ATPase, complex with SbcD (Mre11) | SbcC (TTHA1288) | SbcC | RAD50 | AT2G31970 (RAD50) | Rad50 | RAD50 | Nijmegen breakage syndrome-like disorder | |
| 3′-5′ exonuclease, endonuclease, complex with SbcC (Rad50) | SbcD (TTHA1289) | SbcD | MRE11 | AT5G54260 (MRE11) | Mre11a | MRE11A | Ataxia telangiectasia -like disorder | |
| Accessory protein for MR complex | XRS2 | AT3G02680 (NBS1) | Nbn (Nbs1) | NBN (NBS1) | Nijmegen breakage syndrome | |||
| SMC-like ATPase | RecN (TTHA1525) | RecN | ||||||
| Helicase/nuclease complex | RecB | |||||||
| Helicase/nuclease complex | RecC | |||||||
| Helicase/nuclease complex | RecD | |||||||
| 5′-3′ exonuclease | RecE | |||||||
| ssDNA annealing | RecT | |||||||
| Single-stranded DNA binding protein | SSB (TTHA0244) | Ssb | ||||||
| Single-stranded DNA binding protein complex | RFA (RFA1-3) | RPA (RPA1-3) | Rpa (Rpa1-3) | RPA (RPA1-3) | ||||
| ATPase, complex with RecR | RecF (TTHA0264) | RecF | ||||||
| Recombinase mediator, ssDNA annealing | RecO (TTHA0623) | RecO | ||||||
| DNA binding, complex with RecF and RecO | RecR (TTHA1600) | RecR | ||||||
| Recombinase mediator, ssDNA annealing | Rad52-like (TTHA0081) | RAD52 | Rad52 | RAD52 | ||||
| Recombinase mediator | AT5G01630 (BRCA2B) | Brca2 | BRCA2 | Pancreatic cancer, Ovarian cancer, Breast cancer, Fanconi anemia | ||||
| RAD54 family DNA translocase, recombinase mediator | RAD54 | AT3G19210 (ATRad54) | Rad54l | RAD54L | Adenocarcinoma, Non-Hodgkin lymphoma | |||
| RAD54 family DNA translocase, recombinase mediator | RDH54 | Rad54b | RAD54B | Colon cancer, Non-Hodgkin lymphoma | ||||
| RAD51-like, recombinase mediator | AT5G64520 (XRCC2) | Xrcc2 | XRCC2 | Breast cancer | ||||
| RAD51-like, recombinase mediator | AT5G57450 (XRCC3) | Xrcc3 | XRCC3 | Breast cancer, Melanoma | ||||
| RAD51-like, recombinase mediator | RAD57 | AT2G28560 (RAD51B) | Rad51l1 | RAD51L1 | Uterine leiomyoma | |||
| RAD51-like, recombinase mediator | AT2G45280 (RAD51C) | Rad51c | RAD51C | Fanconi anemia-like disorder, Breast-Ovarian cancer | ||||
| RAD51-like, recombinase mediator | RAD55 | AT1G07745 (RAD51D) | Rad51l3 | RAD51L3 | ||||
| Strand exchange | Recombinase | RecA (TTHA1818) | RecA | AT2G19490 (recA) | ||||
| Recombinase | RAD51 | AT5G20850 (ATRAD51) | Rad51 | RAD51 | ||||
| Branch migration | Branch migration complex | RuvA (TTHA0291) | RuvA | |||||
| Branch migration complex | RuvB (TTHA0406) | RuvB | ||||||
| DNA helicase | RecG (TTHA1266) | RecG | AT2G01440 (RecG) | |||||
| RecA-like ATPase | RadA/Sms (TTHA0541) | RadA/Sms | AT5G50340 | |||||
| RAD54 family DNA translocase, recombinase mediator | RAD54 | AT3G19210 (ATRad54) | Rad54l | RAD54L | Adenocarcinoma, Non-Hodgkin lymphoma | |||
| RAD54 family DNA translocase, recombinase mediator | RDH54 | Rad54b | RAD54B | Colon cancer, Non-Hodgkin lymphoma | ||||
| RECQ family DNA helicase | RecQ | SGS1 | AT1G10930 (RECQ4A) | Blm | BLM | Bloom syndrome | ||
| RECQ family DNA helicase | Wrn | WRN | Werner syndrome | |||||
| RECQ family DNA helicase | AT1G31360 (RECQL2) | Recql | RECQL | |||||
| RECQ family DNA helicase | MPH1 | AT1G35530 | Fancm | FANCM | Fanconi anemia | |||
| Holliday junction resolution | HJ resolvase | RuvC (TTHA1090) | RuvC | |||||
| HJ resolvase | RusA | |||||||
| HJ resolvase | YEN1 | AT1G01880 | Gen1 | GEN1 | ||||
| Structure-specific endonuclease | MUS81 | AT4G30870 (MUS81) | Mus81 | MUS81 | ||||
| complex with MUS81 | MMS4 | AT2G22140 (ATEME1B) | Eme1 | EME1 | ||||
| Structure-specific endonuclease | RAD1 | AT5G41150 (UVH1) | Ercc4 | ERCC4 | Xeroderma pigmentosum | |||
| complex with ERCC4 (RAD1) | RAD10 | AT3G05210 (ERCC1) | Ercc1 | ERCC1 | Cerebro-oculo-facio-skeletal syndrome | |||
| HJ resolvase | SLX1 | AT2G30350 | Slx1 (Giyd2) | SLX1 (GIYD2) | ||||
| Accessory protein for structure-specific nucleases | SLX4 | Slx4 (Btbd12) | SLX4 (BTBD12) | |||||
| Anti-recombination | Recombinase inhibitor | RecX (TTHA0848) | RecX | AT3G13226 (RecX) | ||||
| DNA helicase | UvrD (TTHA1427) | UvrD | SRS2 | AT4G25120 | ||||
| Structure-specific endonuclease | MutS2 (TTHA1645) | AT1G65070 (MutS2) | ||||||
Figure 2A schematic representation of models for direct reversal of DNA damage. The structure of the ATL proteins was modeled by SWISS-MODEL (the template structure is Sulfolobus tokodaii Ogt) [19, 20]. AGT, Ada, and AlkB are not conserved in T. thermophilus. (a) Cyclobutane pyrimidine dimers are recognized by photolyase (TTHB102; PDB ID: 1IQR) and repaired by photolyase. (b) O6-methylguanines are recognized by AGT (PDB ID: 1EH6) in most species and by the C-terminal domain of Ada (PDB ID: 1SFE) in E. coli. Methyl phosphotriesters are recognized by the N-terminal domain of Ada (PDB ID: 1WPK) in E. coli. These enzymes directly accept a methyl group, and the alkyl adducts are removed from the DNA. (c) O6-alkyl adducts including O6-methylguanines are recognized by ATL proteins (TTHA1564; predicted model) in several species. It is predicted that NER proteins are involved in this pathway after recognition of the adducts by ATL proteins. (d) N1-methyladenines and N3-methylcytosines are recognized by AlkB (PDB ID: 2IUW). Methyl group transfer by AlkB depends on α-ketoglutarate and Fe(II).
Figure 3General mechanism of the BER pathway in T. thermophilus. UDGA, UDGB, and AlkA are monofunctional DNA glycosylases. UDGA (PDB ID: 1UI0) and UDGB (PDB ID: 2DDG) remove uracil from DNA. AlkA removes 3-methyladenine in E. coli. MutY and EndoIII are bifunctional DNA glycosylases and have both DNA glycosylase and AP lyase activities. MutY removes adenine opposite 8-oxoG, and EndoIII removes pyrimidine residues damaged by ring saturation, fragmentation, and contraction [41], by which 3′-phospho α,β-unsaturated aldehyde (3′-PUA) remains. MutM (PDB ID: 1EE8) is a trifunctional DNA glycosylase that removes 8-oxoG from oxidatively damaged DNA and 3′-phosphate remains. An AP site resulting from DNA glycosylase activity is processed by EndoIV or multifunctional DNA glycosylases. EndoIV has both AP endonuclease activity and 3′-esterase activity in E. coli [42, 43]. PolX or MutM removes 5′-dRP by dRP lyase activity. In addition, 5′-3′ exonuclease (RecJ) may have dRPase activity. The resulting gap is filled by PolI or PolX followed by sealing of the nick by LigA. The structures of AlkA, EndoIII, MutY, PolI, PolX, and LigA were obtained using SWISS-MODEL [19, 20] (PDB ID: 2H56, 2ABK, 3FSP, 1TAU, 2W9M, and 1V9P, resp.) based on amino acids sequences of T. thermophilus HB8.
Figure 4A schematic representation of models for the nucleotide excision repair pathway controlled by Uvr proteins. All of the predicted protein structures were modeled using SWISS-MODEL. The template structures used in the model building were Geobacillus stearothermophilus UvrA, the N- and C-terminal domain of Thermotoga maritime UvrC, G. stearothermophilus UvrD, Thermus aquaticus DNA polymerase I, Thermus filiformis DNA ligase, and E. coli TRCF. UvrA (TTHA1440; predicted model) and UvrB (TTHA1892; PDB ID: 1D2M) recognize the DNA lesion. In transcribing strand, TRCF (TTHA0889; predicted model) is also involved in recognition of the lesion. UvrC (TTHA1568; predicted model) incises both sides of the lesion. The DNA fragment containing the lesion is excised by UvrD (TTHA1427; predicted model), SSB (TTHA0244; 2CWA), and exonuclease RecJ (TTHA1167; PDB ID: 2ZXO). A new strand is resynthesized by DNA polymerase I (TTHA1054; predicted model) and ligated by DNA ligase (TTHA1097; predicted model).
Figure 5The domain architectures of UvrB, UvrA, and TRCF. (a) UvrB is comprised of five domains. Domains 1a (yellow) and 3 (red) contain helicase motifs. Domain 1b (green) has the flexible β-hairpin invosved in substrate recognition. Domain 2 (blue) interacts with UvrA. Domain 4 is disordered in the crystal structures. (b) UvrA is comprised of six domains: ATP-binding I (red), ATP-binding II (blue), signature I (pink), signature II (cyan), UvrB-binding (yellow), and insertion (green) domain. The white region is the other subunit of the dimer. (c) TRCF is comprised of seven domains. Domains 1 and 2 (not separated in the figure) comprise UvrB homology module (blue). Domains 5 (yellow) and 6 (green) comprise DNA translocation module. Relay helix (yellow) interacts with domain 4 (pink), RNA polymerase interaction domain (RID). The functions of domain 3 (orange) and domain 7 (red) are unclear.
Figure 6A schematic representation of models for MMR pathways in E. coli and mutH-less bacteria. (a) 5′- and 3′-methyl-directed MMR in E. coli. DNA mismatches principally result from misincorporation of bases during DNA replication. The MutS (PDB ID: 1E3M)/MutL (PDB ID: 1NHJ) complex recognizes a mismatch and activates the MutH endonuclease (PDB ID: 1AZO). MutH nicks the unmethylated strand of the duplex to introduce an entry point for the excision reaction. In 3′-methyl-directed MMR, one of the 5′-3′ exonucleases (RecJ and exonuclease VII (ExoVII)) removes the error-containing DNA strand in cooperation with UvrD helicase (PDB ID: 2IS4) and single-stranded DNA-binding protein (SSB; PDB ID: 1EYG). By contrast, one of the 3′-5′ exonucleases (exonuclease I (ExoI; PDB ID: 1FXX) and exonuclease X (ExoX)) is responsible for the 3′-5′ excision reaction. DNA polymerase III (PDB ID: 2HNH) and DNA ligase (PDB ID: 2OWO) synthesize a new strand to complete the repair. (b) A predicted model for 5′- and 3′-nick-directed MMR in T. thermophilus. After recognition of a mismatch by MutS (TTHA1324), MutL (TTHA1323) incises the discontinuous strand of the mismatched duplex to direct the excision reaction to the newly synthesized strand. The error-containing DNA segment is excised by UvrD helicase (TTHA1427), SSB (TTHA0244), and an exonuclease (either RecJ (TTHA1167; PDB ID: 2ZXR) or ExoI (TTHB178)) followed by the resynthesis of a new strand by DNA polymerase III (TTHA0180) and DNA ligase (TTHA1097). The modeled structures of T. thermophilus MutS, MutL (amino acid residues 1–316), ExoI, DNA polymerase III α subunit, DNA ligase, and E. coli RecJ were modeled using SWISS-MODEL. The template structures used for model building were E. coli MutS, the N-terminal domain of MutL, ExoI, UvrD, DNA polymerase III α subunit, DNA ligase, and T. thermophilus RecJ.
Figure 7A schematic pathway of recombination repair and structures of the proteins involved in T. thermophilus. Recombination repair of DSBs is initiated by an end resection step in which DSB ends are processed by the concerted action of RecJ nuclease (TTHA1167; PDB ID: 2ZXR) and SSB (TTHA0244; PDB ID: 2CWA) to form 3′-ssDNA tails. After end resection, the SSB-ssDNA complex is disassembled and RecA recombinase (TTHA1818) is loaded onto ssDNA by “mediators”, RecF (TTHA0264), RecO (TTHA0623), and RecR (TTHA1600), to promote strand invasion. DNA repair synthesis is primed by PolI (TTHA1054) and PolIII (TTHA0180) from the invaded strand of the D-loop structure. Alternatively, second-end capture is mediated by RecO and SSB and branch migration mediated by the RuvA-RuvB complex (TTHA0291-TTHA0406; PDB ID: 1IXR) and RecG (TTHA1266) to yield HJs. HJs are cleaved by RuvC resolvase (TTHA1090) and the nicks sealed by LigA (TTHA1097). Newly synthesized DNA is colored in blue. The model structures of T. thermophilus RecA, RecF, RecO, RecR, PolI, PolIII α subunit, RecG, RuvC, and LigA were generated using SWISS-MODEL. The models were based on the structures of Mycobacterium smegmatis RecA (PDB ID: 2OE2), D. radiodurans RecF (PDB ID: 2O5V), RecO (PDB ID: 1U5K), RecR (PDB ID: 1VDD), E. coli PolI (PDB ID: 1TAU), PolIII α subunit (PDB ID: 2HNH), RuvC (PDB ID: 1HJR), LigA (PDB ID: 2OWO), and Thermotoga maritima RecG (PDB ID: 1GM5).
Figure 8A schematic illustration of RecA-ssDNA interaction in the nucleoprotein filament. (a) A schematic representation of a RecA-ssDNA nucleoprotein filament. The filament comprises a helical structure. RecA molecules are shown as red spheres and the ssDNA as a black line. (b) A schematic model of RecA-ssDNA interaction. The RecA protomer has the L1 and L2 loops and the N-terminal region to make contact with the ssDNA. The bound ssDNA comprises a nucleotide triplet with a nearly normal B-form distance between bases followed by a long internucleotide stretch before the next triplet. The ATP binds to RecA-RecA interfaces. The schematic model was prepared from the crystal structure of RecA-ssDNA complex (PDB ID: 3CMW).